The AtriCure Ablation and Sensing Unit (ASU) is a device that makes linear and transmural lesions in a matter of seconds ...
The Xper Information Management is Philips’ new personalized cardiovascular workflow solution. The product suite ...
Weighing less than 20 pounds, the MyLab30 CV ultrasound system is the first compact ultrasound system to deliver premium ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The Infinix VF-i/SP X-ray system is a universal cardiovascular system designed to accommodate diagnostic and ...
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The ...
Cordis Corp. recently introduced the REGATTA Steerable Guidewire family of devices in the U.S., which 12 selections of ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
May 9 — Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures LLC have announced the creation of a ...
z.one, the first convertible ultrasound system, provides the flexibility to instantly convert from a full-featured, cart ...
Immersion Medical has updated its endovascular platform with features that allow it to simulate a wider range of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
MedicalCV Inc. has received FDA clearance for its SOLAR Surgical Ablation System for the ablation of soft tissue. The ...
The TURBO elite product line for excimer laser ablation is comercially available to treat peripheral artery disease (PAD). The line features an enhanced outer jacket and inner guide wire lumen with optimized ablation efficiency and energy output that enables increased penetration rates.
May 9, 2007 — Biosense Webster Inc., a worldwide leader in cardiac mapping and ablation, and Medtronic Inc., world leader in implanted cardiac rhythm devices, have announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Sometimes it's the smallest things that leave the strongest impression. Of the dozens of technologies with which I came ...
When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.
If the cardiologists at the University of Mississippi Medical Center (UMC) in Jackson have been facing an uphill battle ...
May 08, 2007
